Form 483 Hits the SweetSpot for Alleged Follow-up Issues
The FDA cited a diabetes device data firm for alleged procedural failings in a recent FDA Form 483.
Source: The GMP Letter
The FDA cited a diabetes device data firm for alleged procedural failings in a recent FDA Form 483.
Source: The GMP Letter